Alaunos Therapeutics

unravel break rope tie fray fall apart thread string

Biotech

Texas biotech axes cancer pact, pins hopes on obesity

Alaunos Therapeutics is axing an agreement with Precigen, giving up licensing rights to a personalized T-cell platform.

Gabrielle Masson Oct 11, 2024 11:01am

Money dollars bin drain loss failed

Alaunos winds down sole cell therapy trial, cuts 60% of staff

Aug 15, 2023 10:53am